Background-National guidelines call for participation in systems to rapidly diagnose and treat ST-segment-elevation myocardial infarction (STEMI). In order to characterize currently implemented STEMI reperfusion systems and identify practices common to system organization, the American Heart Association surveyed existing systems throughout the United States. Methods and Results-A STEMI system was defined as an integrated group of separate entities focused on reperfusion therapy for STEMI within a geographic region that included at least 1 hospital that performs percutaneous coronary intervention and at least 1 emergency medical service agency. Systems meeting this definition were invited to participate in a survey of 42 questions based on expert panel opinion and knowledge of existing systems. Data were collected through the American Heart Association Mission: Lifeline website.
Between April 2008 and January 2010, 381 unique systems involving 899 percutaneous coronary intervention hospitals in 47 states responded to the survey, of which 255 systems (67%) involved urban regions. The predominant funding sources for STEMI systems were percutaneous coronary intervention hospitals (n = 320, 84%) and /or cardiology practices (n = 88, 23%). Predominant system characteristics identified by the survey included: STEMI patient acceptance at percutaneous coronary intervention hospital regardless of bed availability (N = 346, 97%); single phone call activation of catheterization laboratory (N = 335, 92%); emergency department physician activation of laboratory without cardiology consultation (N = 318, 87%); data registry participation (N = 311, 84%); and prehospital activation of the laboratory through emergency department notification without cardiology notification (N = 297, 78%). The most common barriers to system implementation were hospital (n = 139, 37%) and cardiology group competition (n = 81, 21%) and emergency medical services transport and finances (n = 99, 26%). the existing delays to reperfusion, the barriers to timely treatment, and the success of early model STEMI systems, 16 the American Heart Association (AHA) embarked on Mission: Lifeline, an initiative to improve the quality of care and outcomes for patients with STEMI and to improve the healthcare system readiness and response to STEMI. An important focus of Mission: Lifeline is to increase the number of patients with timely access to primary PCI.
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In order to characterize currently implemented STEMI reperfusion systems and identify practices common to system organization and potential best practices, the AHA surveyed existing systems throughout the United States.
Methods
We developed a 42-question survey based on expert panel opinion and knowledge of existing systems (online-only Supplemental Data Appendix A). Survey questions focused on processes of care for the diagnosis, system activation, and treatment of STEMI. The survey also examined resource allocation, financial considerations, and the most significant barriers to implementing systematic care. Survey data were collected through the AHA website (Register Your System) (online-only Supplemental Data Appendix A). In addition to posting the survey on the website, registration of existing STEMI networks was encouraged at local, regional, and national meetings involving the treatment of STEMI and by the AHA staff of 8 regional affiliates covering all 50 states. The survey was initially made available in April 2008, and responses through January 2010 were analyzed. The survey took approximately 60 minutes to complete and was deployed using online survey software (Vovici Corporation). For the majority of questions, multiple responses were allowed. For the purposes of this survey, a STEMI system was defined as an integrated group of separate entities focused on reperfusion therapy for STEMI within a geographic region that included at least 1 hospital that performs PCI and at least 1 EMS agency.
In order to avoid double counting, all new system submissions were reviewed on a monthly basis. Any system that did not meet the system definition based on their responses was not included in the data. Duplicate responses were identified using 1 of 2 methods: 1) the regional AHA office reported a duplicate; or 2) the response was from the same individual, agency, and address. Systems that had multiple submissions were contacted by an AHA staff member to verify which submission should be kept in the systems database. To consider the representativeness of the survey, responses were categorized by state and as a function of the number of PCI hospitals.
Results
A total of 381 unique systems involving 899 PCI hospitals from 47 states responded to the survey ( Figure 1A and 1B and online-only Supplemental Data Appendix B). Of these systems, 202 involved a single PCI hospital, 150 encompassed 2 to 5 PCI hospitals, and 29 included >5 PCI hospitals (onlineonly Supplemental Data Appendix C). The systems identified affiliations with 3539 non-PCI hospitals, some of which may have been counted by more than 1 system. From a geographic perspective, 279 (74%) involved rural regions, and 255 (67%) involved urban regions; 228 (60%) were countybased; 190 (50%), city-based; 620 (16%), state-based, and 87 (23%) crossed state lines. The predominant funding sources for STEMI systems are shown in Figure 2 . A broad array of groups provided STEMI system oversight, including cardiology, emergency medicine, emergency departments (ED), hospital and catheterization laboratory administration,
WHAT IS KNOWN
• Coronary reperfusion can be greatly accelerated by coordinated care between hospitals and emergency medical services in a region.
WHAT THE STUDY ADDS
• In a large national survey, several processes were commonly implemented, including accepting patients at a PCI hospital regardless of bed availability, single phone call activation of catheterization laboratory, emergency department physician activation of a laboratory without cardiology consultation, national data registry participation, and prehospital activation of the catheterization laboratory by paramedics and transferring physicians.
• The most commonly reported barriers to system implementation were hospital and cardiology group competition and EMS transport and finances. 
EMS Organization
A number of survey questions involved EMS organization and protocols. Most systems responded to potential STEMI calls using a combination of paramedic and lower level emergency medical technician-staffed ambulances (N = 237, 62%), while 115 systems (30%) had only basic or intermediate-level emergency medical technician-staffed vehicles, and 249 systems (66%) included helicopter transport. More than one half of systems (N = 209, 55%) reported the availability of 12-lead electrocardiograms (ECGs) in their vehicles, and it was available in some but not all for an additional 155 (41%) systems. The ability to transmit ECGs to the receiving hospitals for all ambulances was available in 132 (35%) of systems, and an additional 135 systems (36%) could transmit ECGs in some ambulances. The most commonly reported methods of ECG interpretation were transmission to a hospital (N = 184, 68%), paramedic interpretation (N = 170, 63%), and computer interpretation (N = 92, 34%). When a prehospital ECG revealed a STEMI, the catheterization laboratory was activated through ED notification without the involvement of cardiology for 297 systems (78%); 72 systems (19%) involved a cardiologist for activation; and 58 systems (15%) enabled an emergency medical technician to directly activate the laboratory. The EMS performance measures routinely tracked and reviewed are shown in Figure 4 . The most commonly reported frequencies of laboratory cancellation were <10% (N = 202, 54%), 10% to 24% (N = 79, 21%), and >25% (N = 14, 4%). Two hundred and twenty seven (61%) systems reported that protocols were in place to allow for diversion to a PCI hospital for patients diagnosed with a STEMI by a prehospital ECG. Most of these protocols were implemented independent of legislation (N = 186, 82%); while 41 systems (18%) indicated that destination protocols were supported by legislation. Seventy seven systems (21%) reported the use of prehospital fibrinolysis (sometimes, 52 systems; routinely, 25 systems).
PCI Hospitals
Regarding PCI hospitals involved in the STEMI systems, 346 (97%) accepted STEMI patients regardless of bed availability, 335 (92%) could activate the catheterization laboratory with a single call, 318 (87%) permitted emergency physicians to activate the laboratory without cardiology consultation, and 311 (84%) participated in a data registry. The most frequently reported registries were National Cardiovascular Data Registry (NCDR) Cath PCI (N = 201, 61%), NCDR Acute Coronary Treatment and Intervention Outcomes Network (ACTION) (N = 114, 35%), Get With The Guidelines (N = 89, 27%), and local or program-specific registries (N = 72, 22%). Common performance measures at the PCI hospital are shown in Figure 5 . Most systems provided feedback on performance to the ED at the PCI hospital (N = 318, 84%) and to emergency medical personnel (N = 285, 75%), and 175 systems (46%) provided feedback to the referring hospital ED. The most common time frame for feedback was 24 hours to 1 week (N = 173, 46%), with 135 systems (36%) providing 
Reperfusion Strategy
The most frequent reperfusion strategy employed by non-PCI hospitals involved a mixed strategy employing both fibrinolysis and PCI (N = 198, 52%); 135 systems (36%) predominantly referred for a PCI strategy, and 69 systems (18%) involved a fibrinolysis strategy. Among patients treated with fibrinolysis, 256 systems (81%) transferred these patients on an emergency basis to PCI hospitals, 35 systems (11%) routinely transferred patients on a nonurgent basis, and 24 systems (8%) did not routinely transfer fibrinolysis patients unless their clinical condition necessitated it later. For patients requiring transport to PCI hospitals, local EMS was used by 241 systems (63%), air transport by 168 systems (44%), and mobile intensive care unit sent by the PCI hospital for 48 systems (13%). Reperfusion protocols for non-PCI hospitals included standardized protocols specifying adjunctive anticoagulation (N = 244, 78%), transfer by the same EMS unit that brought the patient to the non-PCI hospital (N = 136, 36%), avoidance of intravenous infusions (N = 73, 19%), and reduced-dose fibrinolysis before transfer for PCI (N = 25, 7%).
Barriers to System Implementation
The final question about barriers to the optimal functioning of the STEMI system allowed respondents to choose >1 response and to identify additional barriers not listed among the possible responses provided. The most common barriers were hospital competition (N = 139, 37%), EMS transport and finances (N = 99, 26%), competition between cardiology groups (N = 81, 21%), lack of data collection and feedback (N = 68, 18%), lack of infrastructure support and funding (N = 59, 16%), and lack of bed availability (N = 59, 16%). Additional responses, many of which included free text, are listed in the online-only Supplemental Data Appendix.
Discussion
Recognizing the importance of regional coordination of EMS and hospitals for the rapid diagnosis and treatment of STEMI, the 2009 update of the American College of Cardiology/AHA STEMI Guidelines added a new Class I recommendation that "each community should develop a STEMI system of care." 14 This report presents the first national survey of STEMI systems, examining implementation from multiple perspectives, including funding, data, and specific EMS and hospital protocols. Respondents identified the widespread application of a number of interventions likely to improve treatment times, including direct activation of the catheterization laboratory by paramedics and emergency physicians, destination or hospital bypass protocols, interhospital transfer protocols, data collection using national data instruments, and timely feedback to healthcare providers involved in STEMI care. The survey also revealed common barriers to regional STEMI care with competition, EMS finances, and data collection being the predominant challenges. These findings should assist ongoing efforts to organize regional care by identifying common approaches to systematic problems and by defining those challenges most frequently shared by systems that warrant the greatest investment of additional resources. Moreover, those systems registered with Mission: Lifeline are now part of a STEMI system community that may share new information, resources, and best practices through the AHA's social network (http:// mlcommunity.heart.org).
A number of interesting themes emerged from the inquiry. By far, the most frequent source of funding for STEMI systems was the PCI hospitals. Additional funding was derived from a broad array of industry, government, and foundation sources. As PCI hospitals have a mandate from the Center for Medicare & Medicaid Services to provide timely reperfusion and report their results publicly, these hospitals have additional incentive to improve the speed of coronary reperfusion 19, 20 ; however, the Center for Medicare & Medicaid Services mandate does not entirely explain the finding, as patients transferred from other hospitals to PCI hospitals are excluded from the measures. PCI hospitals have incentives to support the development of STEMI systems above and beyond improving the quality of care, which include increasing catheterization laboratory volume and to be recognized as an exceptional regional facility in the provision of cardiac care. It is interesting that so few systems identified payers as a source of support. The financial interests of health insurers are not limited to a single hospital or physicians group. Potentially, payers have much to gain from more coordinated and rapid treatment of patients with STEMI, including better outcomes for their beneficiaries manifested as fewer complications, shorter hospitalizations and lower use of medical care after discharge. 21 Greater payer support for STEMI systems will likely require additional evidence to build a business case for coordinated rapid coronary reperfusion.
More than half of the STEMI systems reported the availability of ECGs in emergency medical vehicles, with approximately two-thirds having the capability to transmit ECGs in some or all of their ambulances. The predominant method for EMS to activate the catheterization laboratory involved communication with the receiving ED, while some systems permitted emergency medical technicians to directly activate the laboratory team. Most importantly, the survey identified continued opportunities to improve STEMI care, particularly by establishing protocols for early laboratory activation for all patients with the prehospital diagnosis of STEMI, as well as by expanding the 12-lead ECG capability on ambulances. According to this survey, STEMI protocols can be established without the need for legislation for the majority of systems.
For hospitals lacking PCI facilities, ~one half reported the use of a mixed strategy of fibrinolysis and PCI while an additional third relied on a transfer for a PCI strategy. Patients treated with fibrinolysis were urgently transferred to PCI-capable hospitals for most STEMI systems, indicating that provisions for rapid transfer represent an important component for STEMI treatment, even in the systems initially relying on fibrinolysis. This approach is consistent with randomized trials and current guidelines supporting transfer of higher-risk patients treated with fibrinolysis. 14, 22, 23 Local EMS transfer was more commonly reported than air transport, likely a function of distances between facilities among the systems surveyed. The fact that only 8% of non-PCI capable hospitals do not routinely transfer patients after fibrinolytic therapy provides important insight into the role of the PCI center for the vast majority of patients with STEMI, even those presenting to non-PCI centers.
Commonly reported barriers to STEMI systems included competition between hospitals and physician groups, funding, and data collection. Medical care in the United States is traditionally organized by hospitals, physician practices, and EMS. These reported barriers reflect deficiencies of our healthcare system in providing adequate support to allow for coordinated patient care among these entities. In particular, fiscal horizons that end at the hospital or ambulance door may not allocate adequate funds for STEMI systems. Furthermore, in this traditional model, competition between hospitals and physician groups discourages collaboration in a joint and systematic fashion.
The lack of support for the development of STEMI systems may be remedied through a number of approaches. As above, public reporting of performance measures that extend beyond traditional borders, such as first medical contact to reperfusion, will provide an incentive to hospitals and EMS to collaborate. Support for STEMI systems may also be encouraged by involving entities with medical and fiscal responsibilities that span multiple hospitals, physician groups, and EMS such as large payers and government agencies. It has been suggested that the most attractive proposition for payment reform would be to create a single prospective payment that covers care from first medical contact to interhospital transfer, if appropriate, that would allow EMS and both hospitals to share gains resulting from the coordination of patient care and that would remove the inefficiencies inherent in the payment system. 24 Finally, collaborative systems may be fostered by private or public foundations wishing to have a measurable effect on one of the leading causes of death.
Limitations
The most significant limitation of this survey is likely related to our definition of a system requiring at least 2 hospitals and 1 EMS agency. By giving equal weight to responses regardless of system size, the responses of larger systems involving larger numbers of EMS and hospitals are underrepresented in our cumulative approach. If larger systems substantially differed from smaller systems according to processes of care, resources, and barriers, our survey responses may not adequately reflect issues in these larger systems. A second limitation of our methods involves the framing of survey questions. Although our questions were derived from an expert panel familiar with STEMI system issues and we included some open-ended queries, it is possible that significant issues in implementation were not identified owing to a lack of questions pertaining to such issues. A third limitation of our technique involves our reliance on voluntary participation and self reporting. Biases may have been introduced by selecting respondents more likely to participate in a system survey and by the provision of answers that were not fully reflective of the corresponding system. The 381 responding systems, including 899 hospitals with PCI facilities, representing approximately 66% of the 1355 hospitals identified as having PCI facilities according to the American Hospital Association. 25 A final limitation involves our question concerning systematic use of prehospital fibrinolysis. The 21% rate appears high compared with practical experience, and we believe that some respondents possibly misinterpreted this question to include fibrinolysis administered at a transferring hospital.
In conclusion, this survey of 381 STEMI systems broadly describes the organizational characteristics of collaborative efforts by hospitals and EMS to provide timely reperfusion in the United States. We identified a number of common approaches to STEMI diagnosis and coronary reperfusion, and we identified major barriers that must be overcome in order to implement systematic care. These findings serve as a benchmark to existing systems and to regions in the process of organizing care for STEMI patients and provide a foundation for the ongoing implementation of Mission: Lifeline across the country.
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